INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.42
arrow_downward
-0.70%(-0.0100) 1D
Nov 16, 1:24:46 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.42
High
$1.48
Low
$1.37
Mkt. cap
265.98M
Avg. vol.
19.34M
Volume
3.39M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$0.80
Beta
1.71
Shares outstanding
187.31M
No. of employees
112
Open
$1.42
High
$1.48
Low
$1.37
Mkt. cap
265.98M
Avg. vol.
19.34M
Volume
3.39M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$0.80
Beta
1.71
Shares outstanding
187.31M
No. of employees
112
News stories
From web sources and news partners
ChartMill
·
49 minutes ago
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
marketscreener.com
·
54 minutes ago
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Stocktwits
·
55 minutes ago
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Traders Union
·
2 hours ago
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com